Plastikkirurgisk Center Århus Speciallægecenter ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.5% 0.5% 0.6% 0.6% 0.6%  
Credit score (0-100)  99 99 97 97 98  
Credit rating  AA AA AA AA AA  
Credit limit (kDKK)  3,047.9 3,654.2 4,612.4 4,894.6 6,368.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  4,429 5,239 6,675 4,959 7,934  
EBITDA  3,298 4,025 5,558 3,842 6,686  
EBIT  2,753 3,526 5,063 3,384 6,230  
Pre-tax profit (PTP)  7,422.3 6,559.4 11,462.7 4,565.1 15,062.9  
Net earnings  6,807.9 5,735.9 9,615.4 4,164.1 12,929.3  
Pre-tax profit without non-rec. items  7,422 6,559 11,463 4,565 15,063  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  18,137 17,797 17,308 16,855 16,874  
Shareholders equity total  28,860 34,595 44,098 48,147 60,959  
Interest-bearing liabilities  9,667 9,064 8,430 18,047 12,460  
Balance sheet total (assets)  39,919 45,053 54,423 67,747 74,588  

Net Debt  -4,841 -6,587 -12,380 1,253 -7,062  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,429 5,239 6,675 4,959 7,934  
Gross profit growth  16.3% 18.3% 27.4% -25.7% 60.0%  
Employees  2 2 2 2 2  
Employee growth %  100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  39,919 45,053 54,423 67,747 74,588  
Balance sheet change%  18.7% 12.9% 20.8% 24.5% 10.1%  
Added value  3,297.7 4,025.5 5,557.7 3,878.7 6,685.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -816 -840 -984 -911 -437  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  62.2% 67.3% 75.8% 68.2% 78.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  20.3% 15.6% 23.1% 10.9% 22.2%  
ROI %  20.9% 16.2% 23.9% 11.2% 22.6%  
ROE %  26.7% 18.1% 24.4% 9.0% 23.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  72.3% 76.8% 81.0% 71.1% 81.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -146.8% -163.6% -222.8% 32.6% -105.6%  
Gearing %  33.5% 26.2% 19.1% 37.5% 20.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.4% 0.8% 0.5% 15.6% 4.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  14.0 10.8 11.4 2.4 4.2  
Current Ratio  14.0 10.8 11.4 2.4 4.2  
Cash and cash equivalent  14,508.8 15,650.8 20,809.6 16,794.7 19,522.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  604.4 2,176.4 3,795.8 212.2 1,723.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  1,649 2,013 2,779 1,939 3,343  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,649 2,013 2,779 1,921 3,343  
EBIT / employee  1,377 1,763 2,531 1,692 3,115  
Net earnings / employee  3,404 2,868 4,808 2,082 6,465